NLRP3 as Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer Cells

Hyperglycemia, obesity and metabolic syndrome are negative prognostic factors in breast cancer patients. Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, achieving unprecedented efficacy in multiple malignancies. However, ICIs are associated with immune-related adverse event...

Descripción completa

Detalles Bibliográficos
Autores principales: Quagliariello, Vincenzo, De Laurentiis, Michelino, Cocco, Stefania, Rea, Giuseppina, Bonelli, Annamaria, Caronna, Antonietta, Lombari, Maria Cristina, Conforti, Gabriele, Berretta, Massimiliano, Botti, Gerardo, Maurea, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589802/
https://www.ncbi.nlm.nih.gov/pubmed/33096896
http://dx.doi.org/10.3390/ijms21207802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589802/
https://www.ncbi.nlm.nih.gov/pubmed/33096896
http://dx.doi.org/10.3390/ijms21207802

Ejemplares similares